Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting central nervous system disorders. Its structure supports the development of novel therapeutics due to the presence of the trifluoromethylbenzothiazole moiety, which enhances metabolic stability and binding affinity. Commonly employed in the discovery of receptor modulators and enzyme inhibitors, especially in studies related to dopamine and serotonin receptors. Also utilized in agrochemical research for designing new active ingredients with improved efficacy and environmental profiles.